AI Abundance Meets Fiscal Constraint: Nvidia, SaaS, America’s Debt and the Rise of Personalized Cancer Vaccines

Author’s Note and Disclaimer:
Zion Zhao Real Estate | 88844623 | 狮家社小赵 | wa.me/6588844623 |  https://linktr.ee/zionzhao

This post is for general information, education, and market literacy only. It does not constitute financial, investment, trading, legal, tax, accounting, or other professional advice, and is not an offer, solicitation, recommendation, or endorsement. Views expressed are personal, general in nature, and subject to change without notice. While reasonable care is taken, no representation or warranty is given as to accuracy, completeness, or reliability. Readers should conduct independent due diligence and seek professional advice. To the fullest extent permitted by law, no liability is accepted for any loss arising from reliance on this material.  

The Technology Supercycle Is Accelerating: What Nvidia, SaaS, U.S. Debt and Cancer Vaccines Tell Us About the Next Decade

AI Abundance Meets Fiscal Constraint: Nvidia, SaaS, America’s Debt and the Rise of Personalized Cancer Vaccines

The defining story of 2026 is not simply artificial intelligence. It is the collision between accelerating technological capability and institutions struggling to adapt.

From humanoid robots and AI agents to Nvidia’s historic earnings, Salesforce’s resurgence, America’s US$40 trillion debt burden and personalized mRNA cancer vaccines, the same structural theme keeps emerging: technology is moving faster than economics, regulation and public institutions can comfortably absorb.

Nvidia’s latest quarter captures the scale of the AI infrastructure boom. The company reported US$96.2 billion in quarterly revenue and nearly US$59.7 billion in GAAP net income, while Data Center revenue surged to US$89 billion (Nvidia, 2026). These numbers confirm that AI capital expenditure remains extraordinarily strong.

But record spending does not automatically prove every AI investment will earn attractive returns. History shows that transformative infrastructure booms can create enormous long-term value while simultaneously producing pockets of overinvestment. Railways, telecommunications and the internet all followed that pattern.

The investment question is therefore no longer whether AI is real. It is where durable economic value ultimately accrues.

Salesforce offers an important clue.

The company reported US$11.3 billion in quarterly revenue and raised full-year guidance, challenging the simplistic “SaaS is dead” narrative (Salesforce, 2026). AI may make software development cheaper, but enterprises do not buy software merely because they cannot write code.

They pay for security, permissions, integrations, auditability, compliance, reliability and authoritative data.

In an agentic AI economy, these systems of record may become even more important. AI agents can reason probabilistically, but businesses still require deterministic answers to questions such as contract value, payment status, customer history and approved pricing.

The future enterprise stack may therefore become:

trusted data, applications, APIs, autonomous agents and conversational interfaces.

AI may disintermediate the user interface without destroying the underlying system.

The same distinction applies to employment. Research involving more than 5,000 customer-support workers found that generative AI increased productivity by approximately 15 percent, with particularly strong gains among less experienced employees (Brynjolfsson et al., 2025). That suggests AI may initially reorganize jobs at the task level before eliminating entire occupations.

The greater macroeconomic concern lies elsewhere.

United States public debt has crossed US$40 trillion, while the Congressional Budget Office projects persistent deficits and rising debt relative to GDP (CBO, 2026). The Government Accountability Office estimates that roughly US$9.7 trillion of Treasury securities must be refinanced during fiscal 2026 (GAO, 2026).

That does not mean America is suddenly insolvent. It means refinancing increasingly expensive debt could consume greater fiscal capacity.

Long-term Treasury yields above 5 percent therefore matter not because they prove an imminent sovereign crisis, but because higher borrowing costs compound over time.

The solution is also more complicated than simply blaming government spending. Fiscal expansion contributed materially to pandemic-era inflation, but supply disruptions, energy prices, monetary conditions and demand shifts also mattered (di Giovanni et al., 2023, 2024).

America needs both stronger productivity growth and greater fiscal discipline.

AI could help enormously by lifting output, wages and tax revenues. But technology is not a substitute for budgeting.

Perhaps the most profound development is occurring in medicine.

Merck and Moderna announced positive Phase 3 results for intismeran autogene, a personalized mRNA neoantigen cancer vaccine used with pembrolizumab in high-risk melanoma (Merck & Moderna, 2026). Earlier peer-reviewed Phase 2b data had already shown promising improvements in recurrence-free survival (Weber et al., 2024).

The breakthrough is conceptually extraordinary.

Tumor DNA can be sequenced, mutations identified, individualized neoantigens selected and an mRNA therapy manufactured to train the immune system against molecular signatures unique to a patient’s cancer.

This is programmable medicine.

But scientific enthusiasm must remain disciplined. The therapy is investigational, detailed Phase 3 results remain pending, it requires multiple doses, and positive results in melanoma do not mean mRNA has “cured cancer.” A separate BioNTech colorectal cancer vaccine trial was recently terminated after failing to demonstrate sufficient benefit.

The lesson is broader than oncology.

The biggest analytical mistake today is linear extrapolation.

AI can code, therefore SaaS disappears.

AI can perform knowledge work, therefore knowledge workers disappear.

Nvidia demand is enormous, therefore AI investment cannot become excessive.

Debt is rising, therefore America is about to collapse.

A cancer vaccine succeeds, therefore cancer has been solved.

Reality is more complex.

The winners of the next decade will not simply possess the best technology. They will be the institutions capable of combining innovation with evidence, experimentation with accountability, growth with fiscal discipline and artificial intelligence with human judgment.

That is the real competitive advantage of the technology supercycle.

References

Brynjolfsson, E., Li, D., & Raymond, L. (2025). Generative AI at work. The Quarterly Journal of Economics, 140(2), 889–942.

Congressional Budget Office. (2026). The budget and economic outlook: 2026 to 2036.

di Giovanni, J., Kalemli-Özcan, Ş., Silva, A., & Yıldırım, M. A. (2023). Quantifying the inflationary impact of fiscal stimulus under supply constraints. Federal Reserve Bank of New York.

di Giovanni, J., Kalemli-Özcan, Ş., Silva, A., & Yıldırım, M. A. (2024). Pandemic-era inflation drivers and global spillovers. Federal Reserve Bank of New York.

Merck & Co., Inc., & Moderna, Inc. (2026). Merck and Moderna announce Phase 3 INTerpath-001 trial results.

Nvidia Corporation. (2026). NVIDIA announces financial results for second quarter fiscal 2027.

Salesforce, Inc. (2026). Salesforce delivers record second quarter fiscal 2027 results.

U.S. Government Accountability Office. (2026). Federal debt management: Treasury is meeting borrowing needs but the deteriorating fiscal outlook poses risks.

Weber, J. S., et al. (2024). Individualised neoantigen therapy mRNA-4157 plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma. The Lancet, 403, 632–644.

From Nvidia to Cancer Vaccines: Why AI, Enterprise Software and America’s Debt Are Converging Into One Investment Story

For Family Offices, 13O/13U, VCC structures, GIP applicants, international investors, UHNW families and clients considering Singapore for investment, immigration, education or long-term asset allocation, property decisions should be viewed within a wider macroeconomic and portfolio framework.

I dedicate hours daily to market research, due diligence and writing on geopolitics, economics and multiple asset classes. My experience across real estate, equities, digital assets, portfolio construction and Singapore law helps me assess property beyond price alone.

Consider Singapore real estate as part of a diversified portfolio for potential capital appreciation, rental income and lower volatility relative to many risk assets. Engage a property adviser who understands the bigger picture.